Award
National Cancer Institute 11350959
Tumor and immune determinants of effective anti-tumor immunity in renal cell carcinoma
Recipient
Yale University
Award Amount
$661,522.00
Ceiling
$661,522.00
Awarded
June 23, 2026
Identifier
11350959
Research project funded by the National Cancer Institute to study genetic and immune factors influencing anti-tumor immunity in renal cell carcinoma, focusing on immune checkpoint inhibitors targeting the PD-1 pathway.
Description
This project involves research on immune checkpoint inhibitors targeting the PD-1 pathway in renal cell carcinoma, aiming to uncover genetic and immune determinants of effective anti-tumor immunity. The project is funded by the National Cancer Institute and involves large-scale genomic and transcriptomic analyses.